Free Trial

Synopsys, Inc. (NASDAQ:SNPS) Stock Position Lifted by Security National Bank

Synopsys logo with Computer and Technology background

Security National Bank increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 7.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,060 shares of the semiconductor company's stock after buying an additional 685 shares during the quarter. Security National Bank's holdings in Synopsys were worth $4,314,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in SNPS. Dynamic Advisor Solutions LLC bought a new stake in shares of Synopsys during the first quarter valued at approximately $1,000,000. Bancreek Capital Management LP acquired a new stake in Synopsys in the 4th quarter valued at approximately $3,827,000. Wealth Enhancement Advisory Services LLC raised its stake in Synopsys by 3.4% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 20,172 shares of the semiconductor company's stock valued at $8,651,000 after acquiring an additional 655 shares in the last quarter. Cullen Frost Bankers Inc. raised its stake in Synopsys by 5.4% during the 4th quarter. Cullen Frost Bankers Inc. now owns 15,319 shares of the semiconductor company's stock valued at $7,435,000 after acquiring an additional 791 shares in the last quarter. Finally, Andra AP fonden boosted its position in Synopsys by 61.1% during the 4th quarter. Andra AP fonden now owns 11,600 shares of the semiconductor company's stock worth $5,630,000 after acquiring an additional 4,400 shares during the period. 85.47% of the stock is currently owned by institutional investors.

Synopsys Price Performance

Shares of NASDAQ SNPS traded up $8.43 during midday trading on Thursday, reaching $495.70. The company's stock had a trading volume of 1,019,267 shares, compared to its average volume of 1,155,626. Synopsys, Inc. has a one year low of $365.74 and a one year high of $624.80. The company has a market cap of $76.91 billion, a price-to-earnings ratio of 35.79, a price-to-earnings-growth ratio of 3.16 and a beta of 1.11. The company has a 50 day moving average price of $475.90 and a 200 day moving average price of $477.69. The company has a current ratio of 7.02, a quick ratio of 6.85 and a debt-to-equity ratio of 1.01.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period in the prior year, the business posted $3.00 earnings per share. Synopsys's revenue was up 10.3% compared to the same quarter last year. On average, equities research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling

In other news, CFO Shelagh Glaser sold 7,310 shares of Synopsys stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the transaction, the chief financial officer now owns 15,291 shares in the company, valued at approximately $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive now directly owns 1,485 shares in the company, valued at $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 27,686 shares of company stock valued at $13,001,048. Company insiders own 0.62% of the company's stock.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. Needham & Company LLC reiterated a "buy" rating and issued a $650.00 target price on shares of Synopsys in a research report on Thursday, May 29th. KeyCorp set a $540.00 price target on shares of Synopsys in a research report on Tuesday, June 3rd. Mizuho reduced their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Finally, Rosenblatt Securities decreased their price objective on shares of Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a report on Thursday, May 29th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and an average price target of $607.14.

Read Our Latest Research Report on SNPS

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines